Vitek 2 AST-P640 REF 418 579 Gram Positive Susceptibility Card, 20 cards per container, IVD. Intended for use with the Vitek 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae.
Published April 15, 2015 · Recall initiated: February 25, 2015
Summary
FDA records medical device Class III recall Z-1402-2015, published April 15, 2015 and initiated February 25, 2015. Recalling firm: Biomerieux Inc; Status: Terminated; Reported quantity: 2053 cartons; Lot: lot 740340920, expiration 14APR16; lot 740350820, expiration 22JUL16. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The outer carton label and package insert for the recalled product incorrectly lists Streptococcus pneumoniae as an organism for intended use.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux Inc
- Distributor
- Worldwide Distribution to United Kingdom and Turkey. NO U.S. distribution.
- Lot
- lot 740340920, expiration 14APR16; lot 740350820, expiration 22JUL16;
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811September 30, 2026
- FDAVITEK 2 AST-N447 TEST KIT Product reference 424620July 15, 2026
- FDAVITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) oFebruary 11, 2026
- FDAVITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REFMay 1, 2024
- FDAFlurandrenolide Tape, USP, 4 mcg per sq cm, Rx Only. Distributed By: Actavis Pharma, Inc., Parsippany, NJApril 22, 2015
- FDAEbola Virus GP-VP IgS, Catalog No. I-124 virus test kitApril 15, 2015
Questions about this recall
Was Vitek 2 AST-P640 REF 418 579 Gram Positive Susceptibility Card, 20 cards per container, IVD. Intended for use with the Vitek 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae. recalled?
Yes. FDA published recall Z-1402-2015 on April 15, 2015. Reported hazard: The outer carton label and package insert for the recalled product incorrectly lists Streptococcus pneumoniae as an organism for intended use.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail